课题基金 / 基金详情

Novel, engineered bio-inks for 3D printing of complex, perfusable structures

Novel, engineered bio-inks for 3D printing of complex, perfusable structures
用于 3D 打印复杂可灌注结构的新型工程生物墨水
批准号:
2103812
负责人:
Sarah Heilshorn
金额:
$50.13万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-05-01 至 2025-04-30

项目摘要

项目成果

Sarah Heilshorn的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Non-technical AbstractBioprinting, printing with living cells, of three-dimensional tissue has immense future potential, but progress of this emerging technology is limited by a lack of biomaterials that have the necessary mechanical properties to be printable while also having the appropriate biochemical properties to interface with living cells. In particular, biomaterials that enable perfusion, the transport of oxygen, nutrients, and other life-sustaining components, is critically lacking. The need for perfusable structures is perhaps best demonstrated through blood vessel networks, which are required to deliver oxygen and nutrients to living tissue. Perfusable structures are critically important for many other tissues throughout the body including the lymphatic system, airways, and the gastrointestinal tract. To achieve the next generation of printed tissue, this project will develop a family of biomaterials that enable a new biofabrication strategy termed Gelation of Uniform Interfacial Diffusant in Embedded 3D Printing (GUIDE-3DP). The GUIDE-3DP materials will allow rapid fabrication of perfusable networks of interconnected channels with precise control over their shapes and sizes. In Aim 1, fluid-perfusable structures with complex branch points, such as mimics of branched blood vessels will be printed. In Aim 2, materials for gas-perfusable structures will be developed. As a case study, a human intestinal tissue will be printed and evaluated for the transport of oxygen through the printed living material. In Aim 3, materials that enable fabrication of continuous vessels with precise variation of the internal diameters will be developed. As case studies, printed models of (1) vascular stenosis (in which a region of the blood vessel is constricted) and (2) the large intestine (which has a repetitive, pouch-like structure) will be printed. These biomaterials will enable the future fabrication of living tissue mimics for a variety of applications that advance, biomaterials, biotechnology, national health and will further position the US to have global leadership in the emerging field of biomanufacturing. Technical AbstractPerfusion, and specifically perfusion-enabling biomaterials, remains one of the most critical challenges in the formation of three-dimensional (3D) multicellular structures, whether for the purposes of tissue engineering, in vitro models of organ development and disease, or fundamental studies of cell behavior. The challenge of fabricating channels with specified geometry are important for multiple tissues throughout the body, including blood vessels, lymphatics, airways, and the gastrointestinal tract. To address this challenge, this project will develop a family of biomaterials that enable a new biofabrication strategy termed Gelation of Uniform Interfacial Diffusant in Embedded 3D Printing (GUIDE-3DP). Embedded 3D printing involves the fabrication of desired structures within a support material, reducing deformation and buckling due to gravity and enabling the printing of complex structures. The GUIDE-3DP method builds upon this approach by developing an interfacial diffusant strategy to rapidly fabricate perfusable networks of interconnected channels with precise control over the branching geometry and vessel diameters. In Aim 1, fluid-perfusable structures with complex branch points are fabricated. As a biological case study, endothelial cell morphology and phenotype in the bioprinted branch structures will be characterized, with a focus on how matrix mechanics alters cellular response to fluid shear stress. In Aim 2, gas-perfusable structures for controlled oxygen concentration will be fabricated. As a case study, a 3D human intestinal organoid culture model will be printed and evaluated for the role of oxygenation in regulating intestinal stem cell fate. In Aim 3, continuous vessels with precise variation of luminal diameters will be fabricated, as this geometry commonly occurs in many structures in vivo. As case studies, in vitro models of (1) vascular stenosis (in which a region of the blood vessel is constricted), and (2) the large intestine (which has a repetitive, pouch-like structure) will be printed.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/adhm.202200011
发表时间: 2022-07
期刊: ADVANCED HEALTHCARE MATERIALS
影响因子: 10
作者: [Navarro, Renato S., Huang, Michelle S., Roth, Julien G., Hubka, Kelsea M., Long, Chris M., Enejder, Annika, Heilshorn, Sarah C.]
通讯作者: Heilshorn, Sarah C.
3D printing microporous scaffolds from modular bioinks containing sacrificial, cell-encapsulating microgels.
使用含有牺牲性细胞封装微凝胶的模块化生物墨水 3D 打印微孔支架。
DOI: 10.1039/d3bm00721a
发表时间: 2023
期刊: Biomaterials science
影响因子: 6.6
作者: [Seymour,AlexisJ, Kilian,David, Navarro,RenatoS, Hull,SarahM, Heilshorn,SarahC]
通讯作者: Heilshorn,SarahC
RECODE: Real-time analysis and environmental feedback for directed differentiation of liver organoids
  • 批准号:
    2033302
  • 项目类别:
    Standard Grant
  • 资助金额:
    $142.59万
  • 财政年份:
    2021
  • 负责人:
    Sarah Heilshorn
  • 依托单位:
2018 GRC Signal Transduction by Engineered Extracellular Matrices
  • 批准号:
    1824699
  • 项目类别:
    Standard Grant
  • 资助金额:
    $0.95万
  • 财政年份:
    2018
  • 负责人:
    Sarah Heilshorn
  • 依托单位:
New Inks for 3D Bio-Printing based on Bio-orthogonal Click Chemistry
  • 批准号:
    1808415
  • 项目类别:
    Standard Grant
  • 资助金额:
    $45.45万
  • 财政年份:
    2018
  • 负责人:
    Sarah Heilshorn
  • 依托单位:
Design of self-assembling bio-inks for cell-based 3D printing
  • 批准号:
    1508006
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $28.0万
  • 财政年份:
    2015
  • 负责人:
    Sarah Heilshorn
  • 依托单位:
国内基金
海外基金
基于AMPK/PGC-1α信号轴的工程化外泌体靶向调控BMSCs能量代谢重编程在老年机体骨修复中的作用及其机制研究
  • 批准号:
    82370920
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    周名亮
  • 依托单位:
重复荷载作用下ECC材料的疲劳性能及力学模型研究
  • 批准号:
    51408487
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    25.0万元
  • 批准年份:
    2014
  • 负责人:
    寇佳亮
  • 依托单位: